Citations

Mayo Clinic

Showing 10 of 108599 citations.

12th International Symposium for Mechanisms of Vasodilatation: Celebrating the 30th Anniversary of the Announcement of NO as a Vasodilator Molecule
Miller, Virginia M. , Webb, R. Clinton , Vanhoutte, Paul M.

Journal of Cardiovascular Pharmacology | February 18, 2017 | Volume: 69 | Issue: 5 | Pages: 245-247

10.1097/fjc.0000000000000478 | PMID 28221269 Get It

Whole Exome Sequencing Identifies Atypical Welander Distal Myopathy in Patient
Gass, Jennifer , Blackburn, Patrick R. , Jackson, Jessica L. , Harris, Kimberly G., Selcen, Duygu , Dimberg, Elliot L., Atwal, Paldeep S

Journal of Clinical Neuromuscular Disease | February 18, 2017 | Volume: 18 | Issue: 3 | Pages: 152-156

10.1097/cnd.0000000000000164 | PMID 28221306 Get It

Abstract Welander distal myopathy is a rare autosomal dominant disorder characterized by muscle weakness in the hands and feet. Exome sequencing of affected families discovered a segregating p.Glu384Lys pathogenic variant in TIA-1 as the main genetic cause of Welander distal myopathy. TIA-1 encodes an RNA-binding protein which serves as a key component of stress granules. This protein also regulates splicing and translation of mRNA. Our patient developed progressive weakness in his hands and feet during his late 40s that was misdiagnosed as a neuropathy that caused muscle atrophy. Follow-up genetic testing revealed a p.Glu384Lys pathogenic variant in TIA-1, and he was then diagnosed with Welander distal myopathy. Our case report underlines the importance of electrodiagnostic and genetic testing of patients.
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial
Torres, Vicente E. , Chapman, Arlene B., Devuyst, Olivier , Gansevoort, Ron T. , Dandurand, Ann, Ouyang, John , Czerwiec, Frank S., Blais, Jaime D., Investigators, for the TEMPO 4:4 Trial, Perrone, Ronald D. , Investigators, for the TEMPO 4:4 Trial, Torres, Vicente E , Devuyst, Olivier; https://orcid.org/0000-0003-3744-4767

Nephrology Dialysis Transplantation | February 18, 2017 | Volume: 33 | Issue: 3 | Pages: 477-489

10.1093/ndt/gfx043 | PMID 28379536 Get It

Extracellular Vesicles from Bone Marrow-Derived Mesenchymal Stem Cells Improve Survival from Lethal Hepatic Failure in Mice
Haga, Hiroaki , Takahashi, Kenji , Matsuda, Akiko , Yan, Irene K. , Patel, Tushar

Stem Cells Translational Medicine | February 18, 2017 | Volume: 6 | Issue: 4 | Pages: 1262-1272

10.1002/sctm.16-0226 | PMID 28213967 Get It

Abstract Stem cell-based therapies have potential for treatment of liver injury by contributing to regenerative responses, through functional tissue replacement or paracrine effects. The release of extracellular vesicles (EV) from cells has been implicated in intercellular communication, and may contribute to beneficial paracrine effects of stem cell-based therapies. Therapeutic effects of bone-marrow derived mesenchymal stem cells (MSC) and vesicles released by these cells were examined in a lethal murine model of hepatic failure induced by d-galactosamine/tumor necrosis factor-α (TNF-α). Systemically administered EV derived from MSC accumulated within the injured liver following systemic administration, reduced hepatic injury, and modulated cytokine expression. Moreover, survival was dramatically increased by EV derived from either murine or human MSC. Similar results were observed with the use of cryopreserved mMSC-EV after 3 months. Y-RNA-1 was identified as a highly enriched noncoding RNA within hMSC-EV compared to cells of origin. Moreover, siRNA mediated knockdown of Y-RNA-1 reduced the protective effects of MSC-EV on TNF-α/ActD-mediated hepatocyte apoptosis in vitro. These data support a critical role for MSC-derived EV in mediating reparative responses following hepatic injury, and provide compelling evidence to support the therapeutic use of MSC-derived EV in fulminant hepatic failure.
Chondrocyte Attachment, Proliferation, and Differentiation on Three-Dimensional Polycaprolactone Fumarate Scaffolds
Wagner, Eric R. , Parry, Joshua A. , Dadsetan, Mahrokh, Bravo, Dalibel , Riester, Scott M. , Wijnen, André J. van , Yaszemski, Michael J. , Parry, Joshua, van Wijnen, Andre J, Kakar, Sanjeev , van Wijnen, Andre J , Wagner, Eric R

Tissue Engineering Part A | February 18, 2017 | Volume: 23 | Issue: 13-14 | Pages: 622-629

10.1089/ten.tea.2016.0341 | PMID 28375818 Get It

De novo formation of a large cavernoma associated with a congenital torcular dural arteriovenous fistula: case report
Brinjikji, Waleed , Flemming, Kelly D. , Lanzino, Giuseppe , Flemming, Kelly D

Journal of Neurosurgery: Pediatrics | February 17, 2017 | Volume: 19 | Issue: 5 | Pages: 567-570

10.3171/2016.12.peds16600 | PMID 28291420 Get It

The authors report a case of a developmentally normal child with a congenital complex torcular dural arteriovenous fistula (DAVF) who later, in his teenage years, developed several vermian cavernomas within a large cerebellar developmental venous anomaly (DVA). The patient had initially presented with an abnormally large head circumference but no neurological deficits. He underwent several partial embolization procedures in an attempt to decrease the blood supply of the fistula over the course of 8 years. Nine years following initial presentation, he presented with a fourth ventricular hemorrhage, due to development of a new vermian cavernoma adjacent to a previously known vermian DVA and suffered subsequent mild left-sided hemiataxia from which he later recovered. CT angiographic images demonstrated that the vermian DVA drained into the left transverse sinus, which also drained the torcular arteriovenous fistula. A routine follow-up MRI examination 10 years following initial presentation demonstrated interval development of several large cavernomas in the cerebellum, all within the DVA. The patient had no new symptoms at that time and was neurologically intact. This case report highlights the de novo development of multiple cavernous malformations potentially secondary to DAVF-induced venous congestion in a preexisting DVA.
A Critical Look into the 2016 NICE Guidelines: Acupuncture for Low-Back Pain and Sciatica
Trinh, Kien , Diep, Dion , Dorsher, Peter T.

Medical Acupuncture | February 17, 2017 | Volume: 29 | Issue: 1 | Pages: 20-24

10.1089/acu.2016.1209 Get It

De novo 11q deletion including SHANK2 in a patient with global developmental delay
Marcou, Cherisse A. , Jones, April L Studinski , Murphree, Marine I., Kirmani, Salman , Hoppman, Nicole L., Studinski Jones, April L

American Journal of Medical Genetics Part A | February 17, 2017 | Volume: 173 | Issue: 3 | Pages: 801-805

10.1002/ajmg.a.38075 | PMID 28211979 Get It

Biomarker Guidelines for High-Dimensional Genomic Studies in Transplantation: Adding Method to the Madness
Kurian, Sunil M. , Whisenant, Thomas , Mas, Valeria R. , Heilman, Raymond L. , Salomon, Daniel R., Moss, Adyr A. , Abecassis, Michael M. , Kaplan, Bruce , Kurian, Sunil

Transplantation | February 17, 2017 | Volume: 101 | Issue: 3 | Pages: 457-463

10.1097/tp.0000000000001622 | PMID 28212255 Get It